JP2023539476A5 - - Google Patents
Info
- Publication number
- JP2023539476A5 JP2023539476A5 JP2023512755A JP2023512755A JP2023539476A5 JP 2023539476 A5 JP2023539476 A5 JP 2023539476A5 JP 2023512755 A JP2023512755 A JP 2023512755A JP 2023512755 A JP2023512755 A JP 2023512755A JP 2023539476 A5 JP2023539476 A5 JP 2023539476A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20192142.6 | 2020-08-21 | ||
| EP20192142 | 2020-08-21 | ||
| PCT/EP2021/073186 WO2022038281A1 (en) | 2020-08-21 | 2021-08-20 | Annexin a1 n-terminal peptide formulations and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539476A JP2023539476A (ja) | 2023-09-14 |
| JP2023539476A5 true JP2023539476A5 (https=) | 2024-08-27 |
| JPWO2022038281A5 JPWO2022038281A5 (https=) | 2024-08-27 |
Family
ID=72193322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512755A Pending JP2023539476A (ja) | 2020-08-21 | 2021-08-20 | アネキシンａ１のｎ末端ペプチド製剤及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240041977A1 (https=) |
| EP (3) | EP4200320A1 (https=) |
| JP (1) | JP2023539476A (https=) |
| CN (1) | CN116323649A (https=) |
| AU (1) | AU2021327733A1 (https=) |
| CA (1) | CA3192030A1 (https=) |
| ES (1) | ES3031633T3 (https=) |
| HU (1) | HUE071875T2 (https=) |
| PL (1) | PL4200319T3 (https=) |
| WO (2) | WO2022038258A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3192030A1 (en) * | 2020-08-21 | 2022-02-24 | Resother Pharma A/S | Annexin a1 n-terminal peptide formulations and methods |
| WO2024003338A1 (en) * | 2022-06-30 | 2024-01-04 | Resother Pharma A/S | Annexin a1 liquid pharmaceutical composition |
| WO2024189056A1 (en) | 2023-03-13 | 2024-09-19 | Resother Pharma A/S | Annexin a1 administration regime |
| WO2024189054A1 (en) | 2023-03-13 | 2024-09-19 | Resother Pharma A/S | Annexin a1 delayed dosing |
| WO2025083393A1 (en) | 2023-10-16 | 2025-04-24 | Therakind Limited | Antimicrobial use of peptides derived from annexin a1 |
| WO2025083394A1 (en) | 2023-10-16 | 2025-04-24 | Therakind Limited | Antimicrobial use of annexin a1 protein |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9283260B2 (en) * | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| AU2012271453B2 (en) * | 2011-06-15 | 2017-07-06 | Resother Pharma Aps | Anti-inflammatory pharmaceutical products |
| JP6117219B2 (ja) * | 2011-10-14 | 2017-04-19 | バクスアルタ ゲーエムベーハー | 陰イオン交換クロマトグラフィによるタンパク質の精製方法 |
| EP3838285A1 (en) | 2014-04-22 | 2021-06-23 | TXP Pharma GmbH | Peptide analogues with branched amino acid probe(s) |
| CN110302176A (zh) * | 2019-06-25 | 2019-10-08 | 中国人民解放军陆军军医大学 | 一种抗炎多肽纳米药物及制备方法 |
| CA3192030A1 (en) * | 2020-08-21 | 2022-02-24 | Resother Pharma A/S | Annexin a1 n-terminal peptide formulations and methods |
| WO2024003338A1 (en) * | 2022-06-30 | 2024-01-04 | Resother Pharma A/S | Annexin a1 liquid pharmaceutical composition |
-
2021
- 2021-08-20 CA CA3192030A patent/CA3192030A1/en active Pending
- 2021-08-20 ES ES21765917T patent/ES3031633T3/es active Active
- 2021-08-20 EP EP21766151.1A patent/EP4200320A1/en active Pending
- 2021-08-20 CN CN202180050871.2A patent/CN116323649A/zh active Pending
- 2021-08-20 EP EP25169758.7A patent/EP4595950A3/en active Pending
- 2021-08-20 JP JP2023512755A patent/JP2023539476A/ja active Pending
- 2021-08-20 WO PCT/EP2021/073125 patent/WO2022038258A1/en not_active Ceased
- 2021-08-20 WO PCT/EP2021/073186 patent/WO2022038281A1/en not_active Ceased
- 2021-08-20 AU AU2021327733A patent/AU2021327733A1/en active Pending
- 2021-08-20 HU HUE21765917A patent/HUE071875T2/hu unknown
- 2021-08-20 EP EP21765917.6A patent/EP4200319B1/en active Active
- 2021-08-20 US US18/041,729 patent/US20240041977A1/en active Pending
- 2021-08-20 PL PL21765917.6T patent/PL4200319T3/pl unknown
- 2021-08-20 US US18/041,727 patent/US20230295255A1/en active Pending